Literature DB >> 18494240

Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis.

Nikolay Tzaribachev1, Martin Vaegler, Juergen Schaefer, Patrik Reize, Maximillian Rudert, Rupert Handgretinger, Ingo Müller.   

Abstract

Mesenchymal stromal cells are multipotent cells capable of tissue repair and immune modulation. They are primarily found in bone marrow, but are also present in other tissues of mesenchymal origin, such as fatty tissue, muscle, tendons, etc. MSC can easily be obtained by bone marrow aspiration, showing a rapid expansion in vitro. New protocols enable cell culture without the use of animal-derived sera and artificial growth factors. Avascular necroses of the bone may have different causes. AVN in autoimmune and hematological diseases show a strong association with corticosteroid treatment, which is often unavoidable in severe cases. Until recently, core decompression of the affected osseous area was the standard approach. Because of their differentiation properties, easy accessibility and proliferative capacity, autologous MSCs could potentially complement AVN treatment by adding fresh "osteogenic cells" to the healing process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18494240

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  13 in total

Review 1.  Mesenchymal stem cells: a new trend for cell therapy.

Authors:  Xin Wei; Xue Yang; Zhi-peng Han; Fang-fang Qu; Li Shao; Yu-fang Shi
Journal:  Acta Pharmacol Sin       Date:  2013-06       Impact factor: 6.150

2.  Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study.

Authors:  S Rastogi; S R Sankineani; H L Nag; S Mohanty; G Shivanand; K Marimuthu; R Kumar; L Rijal
Journal:  Musculoskelet Surg       Date:  2013-07-14

3.  Effect of Cbfa1 on osteogenic differentiation of mesenchymal stem cells under hypoxia condition.

Authors:  Zhang-Hua Li; Wen Liao; Qiang Zhao; Tang Huan; Pan Feng; Xia Wei; Yang Yi; Ning-Sheng Shao
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 4.  Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head.

Authors:  Cheng Wang; Yu Wang; Hao-Ye Meng; Xue-Ling Yuan; Xiao-Long Xu; Ai-Yuan Wang; Quan-Yi Guo; Jiang Peng; Shi-Bi Lu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Outcome of childhood leukaemia survivors and necrosis of the femoral head treated with autologous mesenchymal stem cells.

Authors:  T de Rojas; S Martínez-Álvarez; S Lerma-Lara; M Á Díaz; L Madero; M Ramírez
Journal:  Clin Transl Oncol       Date:  2017-09-12       Impact factor: 3.405

6.  Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells.

Authors:  Jonathan Ferrand; Danièle Noël; Philippe Lehours; Martina Prochazkova-Carlotti; Lucie Chambonnier; Armelle Ménard; Francis Mégraud; Christine Varon
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

Review 7.  Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.

Authors:  J García-Castro; C Trigueros; J Madrenas; J A Pérez-Simón; R Rodriguez; P Menendez
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

8.  Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head.

Authors:  Zhen-Hong Zhu; Wen-Qi Song; Chang-Qing Zhang; Ji-Min Yin
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

Review 9.  Autologous Stem Cells Combined Core Decompression for Treatment of Avascular Necrosis of the Femoral Head: A Systematic Meta-Analysis.

Authors:  Shibing Xu; Lei Zhang; Hongting Jin; Letian Shan; Li Zhou; Luwei Xiao; Peijian Tong
Journal:  Biomed Res Int       Date:  2017-08-03       Impact factor: 3.411

10.  HIF-1α transgenic bone marrow cells can promote tissue repair in cases of corticosteroid-induced osteonecrosis of the femoral head in rabbits.

Authors:  Hao Ding; You-Shui Gao; Chen Hu; Yang Wang; Chuan-Gui Wang; Ji-Min Yin; Yuan Sun; Chang-Qing Zhang
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.